Editor's Pick Human Pck2(phosphoenolpyruvate Carboxykinase 2, Mitochondrial) Elisa Kit Enjoy 70% Off [ZYHyE86i]

Human PCK2 ELISA Kit

The Editor's Pick Human Pck2(phosphoenolpyruvate Carboxykinase 2, Mitochondrial) Elisa Kit Enjoy 70% Off [ZYHyE86i] is a high-quality assay designed for the quantitative determination of PCK2 in various biological samples. This kit offers a reliable and convenient method for researchers to study the function and expression of PCK2, a key enzyme involved in the mitochondria of human cells. With its exceptional sensitivity and accuracy, this kit is an essential tool for research on metabolism, cancer, and neurodegenerative diseases.

• High Sensitivity: Detects PCK2 levels as low as 0.031 ng/mL.
• Specificity: Minimizes cross-reactivity and ensures accurate results.
• Simple Procedure: Follows a straightforward 90-minute protocol, making it user-friendly.

Product Specifications and Technical Details

The Human PCK2 ELISA Kit is designed to measure PCK2 in serum, plasma, cell culture supernatant, and tissue homogenates. It utilizes a sandwich enzyme-linked immunosorbent assay (ELISA) technique, ensuring precise and reproducible results. The kit includes all necessary reagents, including a PCK2-specific antibody, horseradish peroxidase (HRP) conjugated antibody, and a ready-to-use substrate. The kit provides a detection range of 0.031 ng/mL to 20 ng/mL, with a high signal-to-cutoff (S/CO) ratio for excellent sensitivity.

• Assay Format: 96-well microtiter plate
• Assay Principle: Sandwich ELISA
• Assay Sensitivity: 0.031 ng/mL

Practical Uses and Target Audience

The Human PCK2 ELISA Kit is ideal for researchers studying metabolic pathways, particularly those interested in the role of PCK2 in energy production and disease progression. This kit is highly beneficial for clinical diagnostics, drug discovery, and basic research. It is particularly useful for researchers in the fields of oncology, neurology, and endocrinology.

• Applications: Metabolism research, cancer diagnostics, and neurodegenerative disease studies.
• Target Audience: Biologists, clinical researchers, and pharmaceutical scientists.